What's the Problem?
According to the CDC, 1 in 54 children have been identified with ASD (Autism Spectrum Disorder). These kids are still diagnosed exclusively through observations, standardized behavioral scales, and parent interviews. Numerous studies indicate that in the development of autism there are environmental and genetic factors, deregulated immune responses and alterations in the balance and content of the human gut microbiome. There is consensus among professionals that the early identification and intervention of children with ASD can improve social communication, reduce anxiety and aggression, and improve the general development of these children.
How are they Solving it?
Enteria is a Uruguayan company specialized in the development of innovative services based on the analysis of the human gut microbiome. These services intend to be a powerful tool to help health professionals diagnose and treat their patients. The company is currently developing a scientific based service as a tool to diagnose ASD at an early stage. This service will include metabolomic, genetic and microbiome approach and intends to help millions of families around the world.